Cognitive Frailty is Associated With Elevated Proinflammatory Markers and a Higher Risk of Mortality
- PMID: 35227616
- PMCID: PMC9177532
- DOI: 10.1016/j.jagp.2022.01.012
Cognitive Frailty is Associated With Elevated Proinflammatory Markers and a Higher Risk of Mortality
Abstract
Background: Cognitive impairment and physical frailty are common among older adults and associated with a higher likelihood of adverse health outcomes. These two conditions frequently coexist in the same individual as cognitive frailty, yet few studies have examined the impact of such comorbidity on clinical outcomes or underlying biological mechanisms.
Methods: A total of 1,340 older adults (age ≥60 years old) from the Bambui Cohort Study of Ageing, with a total follow-up of 10 years, were included in this study. Frailty was defined by the accumulation of deficit framework and cognitive impairment based on scores on the MMSE less than 22. In addition, serum IL-6 levels were measured by cytometric bead array assay.
Results: Individuals classified with cognitive frailty had significantly higher serum IL-6 levels compared to the robust, cognitively unimpaired group. Those with cognitive frailty (aOR = 1.97 [1.18-3.27] and prefrailty and cognitive impairment (aOR = 1.83 [1.24-2.69]) had the highest mortality risk over 10 years of follow-up. Higher IL-6 levels were also independently associated with a higher mortality rate (aOR = 1.37 [1.23-1.54]).
Conclusion: Our study shows that cognitive Frailty indicates a vulnerability state and of increasing mortality risk. Our findings also suggested that proinflammatory abnormalities can be viewed as a central phenomenon underlying common age-related problems (e.g., cognitive impairment and Frailty) and outcomes (e.g., mortality).
Keywords: Cognitive frailty; IL-6; aging; inflammation; mortality.
Copyright © 2022 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
References
-
- Panza F, Seripa D, Solfrizzi V, et al. : Targeting cognitive frailty: Clinical and neurobiological roadmap for a single complex phenotype. Journal of Alzheimer’s Disease 2015; 47:793–813 - PubMed
-
- Robertson DA, Savva GM,Kenny RA: Frailty and cognitive impairment—A review of the evidence and causal mechanisms. Ageing Research Reviews 2013; 12:840–851 - PubMed
-
- Kojima G, Iliffe S,Walters K: Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age and ageing 2018; 47:193–200 - PubMed
-
- 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 2021; 17:327–406 - PubMed
-
- Fried LP, Tangen CM, Walston J, et al. : Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146–156 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
